AI helps doctors remember what matters most to cancer patients

NCT ID NCT07147023

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether an AI tool can accurately summarize serious illness conversations between doctors and cancer patients. Researchers will send these summaries to doctors caring for hospitalized patients with advanced cancer. The goal is to see if the summaries are accurate and helpful, and to gather feedback from both doctors and patients. The study involves 60 participants and focuses on improving communication about care goals.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Large Language Model (AI) generated summaries of serious illness conversations
What this could lead to
If successful, this could help doctors quickly understand a patient's care goals, improving communication and ensuring treatments align with what patients want.
What could go wrong
This is a small, early pilot study with only 60 participants, so results may not apply broadly. The AI summaries might be inaccurate or miss important details.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Brigham and Women's Hospital

    Boston, Massachusetts, 02115, United States

  • Dana-Farber Cancer Institute

    Boston, Massachusetts, 02115, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.